Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
6
×
bristol-myers squibb
6
×
clinical trials
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
6
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
alzheimer's disease
biotech
eli lilly
glaxosmithkline
pfizer
abbvie
amgen
cancer
cancer immunotherapy
deals
fda
What
bio
roundup
drug
news
alzheimer’s
biogen’s
biotech
days
nash
week
aducanumab
advanced
alliance
amyloid
angst
annual
approval
arrival
assessed
attention
august
award
bagged
billions
biogen
biopharmaceutical
brammer
bristol
busy
buy
calls
cancer
changing
color
communities
companies
conference
convo
crispr
data
Language
unset
Current search:
biogen
×
" san francisco top stories "
×
" bristol-myers squibb "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
